[News] Horizon 2020 evaluation highlights benefit of cross-border research but points to areas for improvement

February, 02, 2024 | Select Oncology Journal Articles

An in-depth review of Horizon 2020 has reported huge benefits to the European economy and scientific output as well as society but that the programme would have needed three times the budget to fund all the high-quality research applications it received.

For Additional News from OncWeekly – Your Front Row Seat To The Future of Cancer Care –




Sign up for our emails

Trusted insights straight to your inbox and get the latest updates from OncWeekly

Privacy Policy